Oklahoma 2023 2023 Regular Session

Oklahoma Senate Bill SB225 Amended / Bill

Filed 04/06/2023

                     
 
SB225 HFLR 	Page 1 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
HOUSE OF REPRESENTATIVES - FLOOR VERSION 
 
STATE OF OKLAHOMA 
 
1st Session of the 59th Legislature (2023) 
 
ENGROSSED SENATE 
BILL NO. 225 	By: Seifried of the Senate 
 
  and 
 
  Dempsey of the House 
 
 
 
 
An Act relating to public health; amending 63 O.S. 
2021, Section 7301, which relates to diabetes 
prevention reporting; modifying reporting period; 
requiring submission to Governor; requiring 
submission of components of report under certain 
conditions; updating statutory language ; updating 
statutory references; and providing an effective 
date. 
 
 
 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLA HOMA: 
SECTION 1.    AMENDATORY     63 O.S. 2021, Section 7301, is 
amended to read as follows: 
Section 7301. A.  The Oklahoma Health Care Authority and th e 
State Department of Health shall collaborate to identify benchmarks 
and develop goals to reduce the incidence rates of, improve health 
care services for, and control complications resulting from 
diabetes. 
B.  The Authority and the Department shall submit a report to 
the President Pro Tempore of the Senate and, the Speaker of the   
 
SB225 HFLR 	Page 2 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
House of Representatives, and the Governor by January 10th of odd-
numbered years January 10 of every fifth year.  Such report shall 
contain the following information: 
1.  The fiscal impact of all types of diabetes on the Authority, 
the Department, and county health d epartments including the number 
of persons with diabe tes receiving services through the Authority, 
the Department, and county heal th departments; 
2.  The fiscal impact of diabetes on the Authority, the 
Department, and county heal th departments in compariso n to other 
chronic diseases; 
3.  An assessment of the benefits of diabetes prevention 
programs including a summary of funding dire cted to the Authority 
and the Department from the Oklahoma State Legislature; 
4.  A description of coordination between the Au thority and the 
Department including, but not limited to, programs relating to the 
treatment and prevention of all forms of diabet es; 
5.  Detailed action plans for batt ling diabetes with actionable 
items for consideration by the Legislature including, but not 
limited to, steps to reduce the impact of diabete s, pre-diabetes, 
and related diabetes complications; 
6.  Identification of ex pected outcomes of the action steps an d 
benchmarks for controlling and preventing all forms of diab etes; and 
7.  The development of a detailed budget blueprint identifying 
needs, costs, and resources required to implement the plan provided   
 
SB225 HFLR 	Page 3 
BOLD FACE denotes Committee Amendments.  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
  
for in this act section. Such blueprint shall include a budget 
range for all options presented in the plan for con sideration by the 
Legislature. 
C. In addition to the complete re port required by subsection B 
of this section, the Authority or the Department shall , to the 
extent practicable, provide components of the upcoming report as 
listed in subsection B of this sectio n upon request to the President 
Pro Tempore of the Senate, the Speaker of the House of 
Representatives, and the Governor. 
D. The provisions of this act section shall be limited to 
diabetes information, data, initiatives, and programs within the 
Authority and the Department prior to the effective date of this act 
November 1, 2015, unless there is available funding for diabete s in 
each agency that may be used for new research, data collection 
reporting or other requirements of this act section. 
SECTION 2.  This act shall become effective November 1, 2023. 
 
COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 04/06/2023 - 
DO PASS.